Journal of The Academy of Clinical Microbiologists

Register      Login

VOLUME 20 , ISSUE 1 ( January-June, 2018 ) > List of Articles

SHORT COMMUNICATION

Limitations of the 2016 National AIDS Control Organization guidelines regarding Human Immunodeficiency Virus testing in India

Sanjay Bhattacharya, Kasturi Sengupta, Gaurav Goel

Keywords : 4th generation immunoassay, human immunodeficiency virus, India, serological diagnosis, window period

Citation Information : Bhattacharya S, Sengupta K, Goel G. Limitations of the 2016 National AIDS Control Organization guidelines regarding Human Immunodeficiency Virus testing in India. 2018; 20 (1):57-59.

DOI: 10.4103/jacm.jacm_10_17

License: CC BY-NC 4.0

Published Online: 17-08-2024

Copyright Statement:  Copyright © 2018; Wolters Kluwer India Pvt. Ltd.


Abstract

The current article discusses certain limitations of the 2016 National AIDS Control Organization guidelines regarding human immunodeficiency virus (HIV) testing in India. Incorporation of fourth-generation HIV antigen plus antibody tests in the screening test along with the need of immunoblot techniques (such as the western blot) for HIV confirmation would make the guidelines more robust.


PDF Share
  1. Cohen MS, Gay CL, Busch MP, Hecht FM. The detection of acute HIV infection. J Infect Dis 2010;202 Suppl 2:S270-7.
  2. National HIV Counselling and Testing Services (HCTS) Guidelines. GOI/NACO/BSD (ICTC)/OGL/01122016. Government of India. National AIDS Control Organization; December, 2016. Available from: http://www.indiahivinfo.naco.gov.in/naco/resource/national-hiv-counselling-and-testing-services-hcts-guidelines-2016. [Last accessed on 2016 Dec 22].
  3. Padeh YC, Rubinstein A, Shliozberg J. Common variable immunodeficiency and testing for HIV-1. N Engl J Med 2005;353:1074-5.
  4. Hussain T, Sinha S, Katoch K, Yadav VS, Kulshreshtha KK, Singh I, et al. Serum samples from patients with mycobacterial infections cross-react with HIV structural proteins gp41, p55 and p18. Lepr Rev 2007;78:137-47.
  5. VISR Working Group of Global HIV Vaccine Enterprise; Voronin Y, Zinszner H, Karg C, Brooks K, Coombs R, et al. HIV vaccine-induced sero-reactivity: A challenge for trial participants, researchers, and physicians. Vaccine 2015;33:1243-9.
  6. Mahajan VS, Pace CA, Jarolim P. Interpretation of HIV serologic testing results. Clin Chem 2010;56:1523-6.
  7. Roy P, Sahni AK, Jindamwar P. An urgent need for introduction of fourth-generation Ag-Ab based EIA for detection of HIV infection. Med J Armed Forces India 2014;70:89-90.
  8. Pandori MW, Hackett J Jr., Louie B, Vallari A, Dowling T, Liska S, et al. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol 2009;47:2639-42.
  9. Patel P, Bennett B, Sullivan T, Parker MM, Heffelfinger JD, Sullivan PS, et al. Rapid HIV screening: Missed opportunities for HIV diagnosis and prevention. J Clin Virol 2012;54:42-7.
  10. Centers for Disease Control and Prevention (CDC). Detection of acute HIV infection in two evaluations of a new HIV diagnostic testing algorithm – United States, 2011-2013. MMWR Morb Mortal Wkly Rep 2013;62:489-94.
  11. Alexander TS. Human immunodeficiency virus diagnostic testing: 30 years of evolution. Clin Vaccine Immunol 2016;23:249-53.
  12. Kaur R, Basu S, Kaur G, Singh D. Fourth-generation enzyme immunoassays for screening of HIV in blood donors: Need of the hour. Indian J Pathol Microbiol 2011;54:433-4.
  13. Test for AIDS; Labs LP. Available from: https://www.lalpathlabs.com/test-for-aids. [Last accessed on 2018 Apr 02].
  14. Agarwal R, Rewari BB, Shastri S, Nagaraja SB, Rathore AS. Delivery of antiretroviral treatment services in India: Estimated costs incurred under the national AIDS control programme. WHO South East Asia J Public Health 2017;6:94-8.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.